Cohen & Steers’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-26,628
Closed -$9.41M 414
2018
Q3
$9.41M Sell
26,628
-32,684
-55% -$11.3M 0.03% 172
2018
Q2
$17.2M Sell
59,312
-2,268
-4% -$638K 0.05% 130
2018
Q1
$16.9M Buy
61,580
+4,545
+8% +$1.41M 0.05% 125
2017
Q4
$18.2M Buy
57,035
+18,340
+47% +$5.88M 0.05% 137
2017
Q3
$12.1M Buy
+38,695
New +$11.5M 0.03% 159
2016
Q2
Sell
-11,700
Closed -$3.05M 407
2016
Q1
$3.05M Sell
11,700
-13,200
-53% -$3.49M 0.01% 277
2015
Q4
$7.63M Hold
24,900
0.02% 194
2015
Q3
$7.27M Buy
+24,900
New +$8.22M 0.02% 209

Other funds holding BIIB

Cohen & Steers's BIIB Position: Q4 2018 in Review

Cohen & Steers sold out of Biogen (BIIB) in Q4 2018, closing a stake of 26,628 shares — an estimated $9.41M sold.

Cohen & Steers first reported a position in BIIB in Q3 2015 and held it in 8 quarters. The position peaked at $18.2M in Q4 2017. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Cohen & Steers reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Cohen & Steers sold 26,628 Biogen shares in Q4 2018, an estimated $9.41M.
  • Cohen & Steers first reported a position in Biogen in Q3 2015 and held it in 8 quarters.
  • Cohen & Steers's Biogen position peaked at $18.2M in Q4 2017.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Cohen & Steers's 13F filing for Q4 2018, filed 14 Feb 2019.